Funda Meric-Bernstam
Funda Meric-Bernstam
Chair, Department of Investigational Cancer Therapeutics, The UT MD Anderson Cancer Center
Verified email at mdanderson.org - Homepage
Title
Cited by
Cited by
Year
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
14742018
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ...
New England Journal of Medicine 378 (8), 731-739, 2018
12422018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
10972018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
9982018
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer
S Jiralerspong, SL Palla, SH Giordano, F Meric-Bernstam, C Liedtke, ...
Journal of clinical oncology 27 (20), 3297, 2009
9712009
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Y Wang, J Waters, ML Leung, A Unruh, W Roh, X Shi, K Chen, P Scheet, ...
Nature 512 (7513), 155-160, 2014
9052014
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
8942018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
8802018
PD-L1 expression in triple-negative breast cancer
EA Mittendorf, AV Philips, F Meric-Bernstam, N Qiao, Y Wu, S Harrington, ...
Cancer immunology research 2 (4), 361-370, 2014
7682014
Targeting the mTOR signaling network for cancer therapy
F Meric-Bernstam, AM Gonzalez-Angulo
Journal of Clinical Oncology 27 (13), 2278, 2009
7172009
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low-to intermediate-grade neuroendocrine tumors: results of a phase II study
JC Yao, AT Phan, DZ Chang, RA Wolff, K Hess, S Gupta, C Jacobs, ...
Journal of Clinical Oncology 26 (26), 4311, 2008
7102008
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri, K Broglio, SW Kau, M Cristofanilli, AU Buzdar, V Valero, ...
Journal of clinical oncology 24 (7), 1037-1044, 2006
6372006
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
H Masuda, KA Baggerly, Y Wang, Y Zhang, AM Gonzalez-Angulo, ...
Clinical cancer research 19 (19), 5533-5540, 2013
6102013
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer
AM Gonzalez-Angulo, KM Timms, S Liu, H Chen, JK Litton, J Potter, ...
Clinical Cancer Research 17 (5), 1082-1089, 2011
5522011
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor–positive breast cancer
R Jeselsohn, R Yelensky, G Buchwalter, G Frampton, F Meric-Bernstam, ...
Clinical cancer research 20 (7), 1757-1767, 2014
4742014
Targeting the PI3K pathway in cancer: are we making headway?
F Janku, TA Yap, F Meric-Bernstam
Nature reviews Clinical oncology 15 (5), 273-291, 2018
4662018
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller
AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ...
Journal of clinical oncology 27 (34), 5700, 2009
4642009
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
4352018
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium
Cancer discovery 7 (8), 818-831, 2017
4272017
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer
A Melhem-Bertrandt, M Chavez-MacGregor, X Lei, EN Brown, RT Lee, ...
Journal of clinical oncology 29 (19), 2645, 2011
4202011
The system can't perform the operation now. Try again later.
Articles 1–20